|
|
Volumn 43, Issue 9, 2002, Pages 983-992
|
|
A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England
|
|
Author keywords
Adverse events; Gabapentin; Postmarketing surveillance; Pregnancy outcomes; Prescription event monitoring
|
|
Indexed keywords
CARBAMAZEPINE;
FELBAMATE;
GABAPENTIN;
TIAGABINE;
TOPIRAMATE;
ADOLESCENT;
ADULT;
AGE DISTRIBUTION;
AMNESIA;
ANTICONVULSANT THERAPY;
ARTICLE;
ATAXIA;
CHILD;
COHORT ANALYSIS;
CONTROLLED STUDY;
DROWSINESS;
DRUG INDICATION;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG WITHDRAWAL;
EPILEPSY;
FEMALE;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALAISE;
MALE;
NAUSEA;
OUTCOMES RESEARCH;
PREGNANCY;
PRESCRIPTION;
PRIORITY JOURNAL;
RASH;
TREMOR;
UNITED KINGDOM;
VERTIGO;
VISUAL DISORDER;
VOMITING;
ACETIC ACIDS;
ADOLESCENT;
ADULT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
AMINES;
ANTICONVULSANTS;
CAUSE OF DEATH;
CHILD;
CHILD, PRESCHOOL;
CYCLOHEXANECARBOXYLIC ACIDS;
DRUG ERUPTIONS;
DRUG THERAPY, COMBINATION;
ENGLAND;
EPILEPSY;
EXANTHEMA;
FEMALE;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
INFANT;
MALE;
MIDDLE AGED;
PRODUCT SURVEILLANCE, POSTMARKETING;
SLEEP STAGES;
WEIGHT GAIN;
|
|
EID: 0036712989
PISSN: 00139580
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1528-1157.2002.01702.x Document Type: Article |
|
Times cited : (51)
|
|
References (28)
|
